CMAB017
/ Mabpharm Limited
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
September 12, 2025
Safety and Tolerability of CMAB017 In Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=55 | Recruiting | Sponsor: Taizhou Mabtech Pharmaceutical Co.,Ltd | Not yet recruiting ➔ Recruiting
Enrollment open • Oncology • Solid Tumor
April 18, 2025
Safety and Tolerability of CMAB017 In Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=55 | Not yet recruiting | Sponsor: Taizhou Mabtech Pharmaceutical Co.,Ltd
New P1 trial • Oncology • Solid Tumor
1 to 2
Of
2
Go to page
1